Effect of mitoquinone on liver metabolism and steatosis in obese and diabetic rats
Abstract Previous work by ourselves and others showed that mitoquinone (mitoQ) reduced oxidative damage and prevented hepatic fat accumulation in mice made obese with high‐fat (HF) feeding. Here we extended these studies to examine the effect of mitoQ on parameters affecting liver function in rats t...
Main Authors: | Brian D. Fink, Liping Yu, Lawrence Coppey, Alexander Obrosov, Hanna Shevalye, Robert J. Kerns, Mark A. Yorek, William I. Sivitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.701 |
Similar Items
-
Risk Factors for Liver Steatosis in Obese Children and Adolescents
by: Yu-Cheng Lin, et al.
Published: (2010-06-01) -
Progressive Loss of Corneal Nerve Fibers and Sensitivity in Rats Modeling Obesity and Type 2 Diabetes Is Reversible with Omega-3 Fatty Acid Intervention: Supporting Cornea Analyses as a Marker for Peripheral Neuropathy and Treatment
by: Coppey L, et al.
Published: (2020-04-01) -
Insulin Clearance at the Pubertal Transition in Youth with Obesity and Steatosis Liver Disease
by: Roberto Franceschi, et al.
Published: (2023-10-01) -
Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases
by: Hyon-Seung Yi
Published: (2019-03-01) -
Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice
by: Geng-Ruei Chang, et al.
Published: (2021-09-01)